Archive for April 2019

Isai Peimer is a Biotech Analyst at Surveyor Capital (Citadel) where he focuses on public/private investments across the biotechnology sector. From 2010 to 2016, Isai served as a Managing Director at Medimmune Ventures, Astrazeneca’s investment fund. Isai has served as board member of Adheron Therapeutics (Acquired by Roche), Ambit Biosciences (acquired by Daiichi Sankyo), Armaron…

Rob Tarran is a Professor in UNC’s Department of Cell Biology and Physiology and is also a member of UNC’s Lineberger Cancer Center and Marsico Lung Institute. Rob has over 20 years of experience in studying airway disease and is particularly interested in the role of ion channels in disease pathogenesis. Rob has focused on…

David S. Joseph, his career spans forty years of highly successful hospital management and entrepreneurship as a founder of five companies involved in surgical lasers, orthopedic biomaterials, medical devices and pharmaceuticals. Former co-founder, president and chairman Orthovita an orthopedics bio materials company and initiated a public offer and subsequently acquired by Stryker Corporation. He co-founded…

Doug is the CEO of Lungpacer Medical Inc., which is developing a novel Breakthrough Device designed to improved outcomes for critically ill mechanically ventilated patients. He was formerly the Chief Operating Officer of Kensey Nash (KNSY); acquired for $360M by Royal DSM, and prior to that at GE. He is a serial innovator and product…

After working for the Glaxo family of companies for over 20 years, followed by a short period of consulting, I co-founded Respivert Ltd in 2007 to discover novel inhaled anti-inflammatory agents to treat COPD. The company was VC funded and was acquired in 2010. I then I continued to work on the Respivert portfolio of…

Dr. Kan has been working in the pharmaceutical industry for more than 20 years, focused on pharmaceutical formulation technology and product development, published over 50 papers and more than 10 patents related to drug delivery, some of which have been used in clinical products. He is now the President of Pharmosa and has served in…

Dr. Rose is an experienced health care executive with broad experience in science, medicine and medical product development. He is a graduate of Yale College and the Harvard Medical School, where he was an Associate Professor of Medicine and Chief of the Division of Pulmonary and Critical Care Medicine at Beth Israel Deaconess Hospital. He…

Jason found HCmed as a professional firm in the inhaled drug/device combination field. Since 2014, he leads HCmed team to design, develop, and manufacture highly effective mesh nebulizer and successfully invites Vivo capital to be a strategy investor in 2017. Based on the leading-edge mesh nebulizer expertise, combined with the strength of Taiwan’s world-class electrical…

Joe Condurso has more than 30 years of experience across the medical and information technology and services industry. Joe is an accomplished global executive with a successful track record for innovating and commercializing game changing medical devices, clinical information systems, mobile health solutions and telemedicine services within public, venture, and development stage organizations. He has…